Cargando…
Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada
Prostate Specific Membrane Antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is becoming established as a standard of care for the (re)staging of high-risk primary and prostate cancer recurrence after primary therapy. Despite the favorable performance of this imaging modality...
Autores principales: | Young, Sympascho, Metser, Ur, Sistani, Golmehr, Langer, Deanna L., Bauman, Glenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366560/ https://www.ncbi.nlm.nih.gov/pubmed/34408985 http://dx.doi.org/10.3389/fonc.2021.722430 |
Ejemplares similares
-
Validating emergency department cardioversion procedures in provincial administrative data in Ontario, Canada
por: Atzema, Clare L., et al.
Publicado: (2022) -
PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial
por: Ménard, Cynthia, et al.
Publicado: (2022) -
Access to primary care in adults in a provincial correctional facility in Ontario
por: Green, Samantha, et al.
Publicado: (2016) -
Erratum to: Access to primary care in adults in a provincial correctional facility in Ontario
por: Green, Samantha, et al.
Publicado: (2016) -
Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey
por: Kouyoumdjian, Fiona G., et al.
Publicado: (2018)